Overall, the current study demonstrates that low-frequency THz waves can ameliorate the cognitive deficits in APPSWE/PS1DE9 double transgenic mice of AD by decreasing Aβ/tau pathology, rescuing neuronal loss, and ameliorating neuroinflammation and mitochondrial function. This evidence concerns the gene MAPT and Alzheimer disease.